Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Plasmodium Immunotherapy for Advanced Ovarian Cancer

NCT05924776 is registered in ClinicalTrials.gov with CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. as lead sponsor.

NCT NCT05924776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05924776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Plasmodium Immunotherapy for Advanced Ovarian Cancer
Lead sponsor
CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
July 20, 2024
Completion date
March 30, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced ovarian cancer